Search results
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 2 days agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
FTC warns pharma companies it means business with its Orange Book listing policy | JD Supra
JD Supra· 3 days agoLast September, the Federal Trade Commission (FTC) promulgated a “policy statement” entitled “Statement Concerning Brand Drug Manufacturers’ Improper Listing of Patents in ...
Nearly 900K Yogi tea bags voluntarily recalled for elevated levels of pesticide residue
ABC News· 10 hours agoNearly 900,000 bags of Yogi Immune Support tea enhanced with echinacea have been voluntarily...
Ozempic maker Novo Nordisk says it will study drug’s effects on alcohol consumption but isn’t...
CNN via Yahoo Finance· 1 day agoThe company plans to start assessing the effects of semaglutide, the active ingredient in Ozempic,...
China-connected South Bay biotech company called out by Congress in Biosecure Act - San Francisco...
The Business Journals· 2 days agoA San Jose biotech company owned by a Chinese company is at the center of a U.S.-China tug-of-war...
Key drug maker files for Chapter 11 bankruptcy
TheStreet.com· 1 day agoThe Boston-based company files for Chapter 11 bankruptcy to implement a restructuring support agreement. Chapter 11 bankruptcy filings in 2024 by biotech companies and other ...
Don't panic, says stock market boss as firms leave UK
BBC via Yahoo Finance· 2 days agoCambridge-based microchip giant ARM Holdings – once listed in London now sells its shares in New...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks via Yahoo Finance· 13 hours agoThough obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect...
Dow closes above 40,000 for the first time in history. What does it mean for your 401(k)?
The Fredericksburg Free Lance-Star· 5 hours agoThe Dow Jones Industrial Average just closed above 40,000 for the first time, the latest pop in...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 15 hours agoModerna developed mRNA-1345 for use in older adults (aged 60 years and above). The regulatory body...